Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
TransMedics Group Inc
TMDXCurrent price
80.48 USD
-8.45 USD (-9.50%)
Last closed
88.36 USD
Company
www.transmedics.com
ISIN
US89377M1099
Sector
Healthcare
Industry
Medical Devices
Exchange
NASDAQ
Capitalization
2 885 617 920 USD
Yield for 12 month
+17.15 %
1Y
3Y
5Y
10Y
15Y
TMDX
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its OCS includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for preservation of DBD donor hearts deemed unsuitable due to limitations of cold storage and for ex vivo reanimation, functional monitoring, and beating-heart preservation of donation-after-circulatory-death hearts; and OCS Liver for the preservation of DBD and DCD of donor livers. The company also developed national OCS program, a turnkey solution for outsourced organ retrieval; and provides OCS organ management and logistics services, including aviation and ground transportation, and other coordination activity. The company was founded in 1998 and is headquartered in Andover, Massachusetts. Address: 200 Minuteman Road, Andover, MA, United States, 01810
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
139.25 USDP/E ratio
92.4516Dividend Yield
–Current Year
+241 623 000 USD
Last Year
+93 459 000 USD
Current Quarter
+108 761 000 USD
Last Quarter
+114 305 000 USD
Current Year
+153 993 000 USD
Last Year
+65 272 000 USD
Current Quarter
+60 845 000 USD
Last Quarter
+69 161 000 USD
Key Figures TMDX
1 year
3 years
5 years
10 years
EBITDA
51 138 000 USD
Operating Margin TTM
PE Ratio
92.4516
Return On Assets TTM
2.84 %
PEG Ratio
–
Return On Equity TTM
19.41 %
Wall Street Target Price
139.25 USD
Revenue TTM
401 089 984 USD
Book Value
6.26 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
63.7 %
Dividend Yield
–
Gross Profit TTM
65 272 000 USD
Earnings per share
0.93 USD
Diluted Eps TTM
0.93 USD
Most Recent Quarter
III 2024
Quarterly Earnings Growth YOY
–
Profit Margin
8.14 %
Dividend Analytics TMDX
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History TMDX
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation TMDX
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
92.4516
Forward PE
53.7634
Enterprise Value Revenue
7.6633
Price Sales TTM
7.1944
Enterprise Value EBITDA
47.4478
Price Book MRQ
13.7463
Financials TMDX
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators TMDX
For 52 weeks
61.98 USD
177.37 USD
50 Day MA
132.03 USD
Shares Short Prior Month
6 016 782
200 Day MA
122.36 USD
Short Ratio
5
Shares Short
6 439 780
Short Percent
23.34 %
BeatStart